Infinity Jabs By Mrs Vera West

Once upon a time, people would ask how many lumps of sugar, now considered by many including me, a white poison, they wanted in their tea. Now it is question of how many jabs are needed. Apparently three doses of the Pfizer vax are needed, but will even that be enough?

“Australians have been warned they may need a third dose of the Covid-19 vaccine to become fully immunised against the virus.

Pfizer's CEO Albert Bourla said earlier this month he believes most of those inoculated with his company's vaccine will 'likely' need a third dose. 

Pfizer is now the preferred vaccine option for people under the age of 50 in Australia because of the AstraZeneca's link to rare blood clots. 

During a panel discussion which aired in the US on Thursday, Albert Bourla said a potential booster shot would need to be administered within six to 12 months of being fully vaccinated. 

Bourla added he even thinks it is possible the global population will need to be immunised against the coronavirus annually.      

The revelation comes as some of Australia's most senior doctors raised serious concerns with the federal government's rollout of the vaccine.

“As American waits for the CDC to finish a review of blood-clotting risks associated with Johnson & Johnson's COVID-19 vaccine, Pfizer CEO Albert Bourlas has warned reporters that recipients of the Pfizer vaccine - the most widely distributed jab in the US - will "likely" need to receive a third "booster" shot within 12 months of being vaccinated, and possibly as early as six months after receiving their second dose.

The news is hardly a surprise. Comments and rumors about the need for booster shots have been reported by the US media since late last year. But on Thursday, Bourlas said a booster shout would likely be necessary, and that patients may need to be vaccinated against COVID annually, similar to the way that flu vaccines are developed and distributed.

"It is extremely important to suppress the pool of people that can be susceptible to the virus," he told CNBC's Bertha Coombs during an event with CVS Health. Bourlas added that vaccines will need to be used to combat not just COVID, but the evolving mutant strains - or "variants" - like B.1.1.7, known as the "Kent" strain, which has been blamed for some of the botched rollout in the US.

Bourlas isn't the only major public health official warning about the need for booster shots. On Thursday, the Biden administration’s Covid response chief science officer David Kessler said Americans should expect to receive booster shots to protect against coronavirus variants. He noted that while the current crop of COVID jabs is highly effective, they could be "challenged" by the new variants.

New data released earlier this month by Pfizer said that updated data from its clinical trial showed its vaccine to be highly effective six months after the second dose. The data was based on more than 12K vaccinated participants. More data is still needed to determine whether protections last after six months, however. Pfizer and German partner BioNTech began studying a third dose of their vaccine in late February.

The booster shot is aimed at protecting against future variants, which may be better at evading antibodies from vaccine than earlier strains of the virus. About 144 volunteers will be given the third dose, mostly those who participated in the vaccine's early-stage U.S. testing last year.

"We don’t know everything at this moment," he told House Select Subcommittee on the Coronavirus Response. "We are studying the durability of the antibody response," he said. "It seems strong but there is some waning of that and no doubt the variants challenge...they make these vaccines work harder. So I think for planning purposes, planning purposes only, I think we should expect that we may have to boost."

Bourla said the company would likely try out the third doses first on a select group of individuals who participated in the original studies.”

It might be worth watching the quasi-zombie film, I am Legend Again (2007) again.



No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Wednesday, 17 August 2022